Very recently, the news that a male contraceptive pill is in development made much waves on social media.
Now, the pill is set to engage in human trials as scientists in the US embarked on the challenge of developing a non-hormonal male contraceptive pill.
So far, the pill proved to be safe and effective on mice, meaning that clinical trials in humans are set to begin alter this year. The researchers from the University of Minnesota presented their findings at the American Chemical Society’s Spring 2022 conference last month.
The pill is different from those of its type as it does not target testosterone. This means that the risk of side effects is far less than other drugs which never ended up on pharmacy shelves.
As it stands, most female birth controls work on the female sex hormones. ‘Targeting the male sex hormone leads to a lot of side effects such as weight gain, depression and increased risk of cardiovascular diseases’ said researcher Abdullah al Noman.
“Men are less willing to take a birth control pill that has significant side effects. That’s why we are targeting a non-hormonal pathway to developing a male birth control pill.”
Of course, mice are not humans and so the researchers are taking all necessary precautions so that the pills pass peer review safely and effectively.
#MaltaDaily